financetom
Business
financetom
/
Business
/
Update: Lifeway Foods' Two Largest Shareholders Call for Resignations of Board, CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Lifeway Foods' Two Largest Shareholders Call for Resignations of Board, CEO
Jul 19, 2024 10:48 AM

01:26 PM EDT, 07/19/2024 (MT Newswires) -- (Updates with Lifeway Foods' ( LWAY ) comments in the fifth paragraph.)

Two of Lifeway Foods' ( LWAY ) largest shareholders on Thursday called for the resignation of the board and Chief Executive Julie Smolyansky.

Ludmila and Edward Smolyansky, who are the mother and brother of Julie Smolyansky, own 29% of the organic food company.

The shareholders said in statement they are seeking a new independent company with up to eight members, including co-founder and former board member Ludmila Smolyansky, as well as an "anti-nepotism policy" to be added to Lifeway's bylaws and an "operational and strategic review" of the business.

"Lifeway suffers from a pattern of retrenching and silence when faced with criticism, and mediocre results, often doubling down on past failures," Edward Smolyansky said in the statement. "Lifeway's narcissistically driven inability to self-reflect makes it impossible for the brand to achieve its full potential and value in the short and long term."

"Lifeway is performing at historic, record-breaking levels," a Lifeway spokesperson told MT Newswires on Friday. "Lifeway's leadership and board are proud of the incredible growth the brand has achieved since Edward Smolyansky's departure and seek to continue building upon the company's recent success."

Price: 12.06, Change: -0.20, Percent Change: -1.63

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atara Biotherapeutics Q3 revenue beats estimates 
Atara Biotherapeutics Q3 revenue beats estimates 
Nov 12, 2025
Overview * Atara Q3 2025 revenue beats analyst expectations despite a significant year-over-year decline * Company reported a net loss of $4.3 mln for Q3 2025, down from $21.9 mln in 2024 * Atara reduced workforce by 29% to focus on strategic priorities Outlook * Atara expects $40 mln milestone payment upon tab-cel BLA approval * Company projects 2025 operating...
Israeli flavors and fragrances maker Turpaz posts record revenue, boosted by acquisitions
Israeli flavors and fragrances maker Turpaz posts record revenue, boosted by acquisitions
Nov 12, 2025
Overview * Turpaz Q3 sales increased 57.4% yr/yr to $76.7 mln, driven by organic growth and acquisitions * Operating profit for Q3 rose 73.4%, reflecting improved profitability * Company completed six acquisitions in 2025, expanding global presence Outlook * Turpaz did not provide specific future financial guidance Result Drivers * ACQUISITIONS AND ORGANIC GROWTH - Turpaz's Q3 sales growth of...
High Tide Up 0.75% In US Premarket As Says To Open Four New Canna Cabana Locations Across Alberta and Ontario
High Tide Up 0.75% In US Premarket As Says To Open Four New Canna Cabana Locations Across Alberta and Ontario
Nov 12, 2025
09:05 AM EST, 11/12/2025 (MT Newswires) -- Cannabis retailer High Tide (Nasdaq: HITI and HITI.V) was at last look up 0.75% in US premarket trade on Wednesday after announcing that it will open four new Canna Cabana branded locations across Ontario and Alberta, located in Calgary, Scarborough, Kitchener, and Nepean. A statement noted these openings bring High Tide's total store...
Natera Integrates Oncology Tests With Flatiron's Electronic Medical Record  Platform
Natera Integrates Oncology Tests With Flatiron's Electronic Medical Record Platform
Nov 12, 2025
09:06 AM EST, 11/12/2025 (MT Newswires) -- Natera ( NTRA ) said Wednesday it has integrated its oncology testing portfolio with Flatiron Health's electronic medical record platform, OncoEMR, to enable electronic ordering and results delivery for cancer care providers. Financial terms were not provided. The company said the connection allows oncologists to order and receive results for its Signatera and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved